14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SLS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in SELLAS Life Sciences Group Inc. stock price on Wednesday moving 28.51% between high and low
(Updated on May 01, 2024)

Sell candidate since Apr 29, 2024 Gain 5.79% PDF

The SELLAS Life Sciences Group Inc. stock price gained 3.23% on the last trading day (Wednesday, 1st May 2024), rising from $1.24 to $1.28. During the last trading day the stock fluctuated 28.51% from a day low at $1.12 to a day high of $1.44. The price has risen in 5 of the last 10 days but is still down by -9.22% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 8 million more shares were traded than the day before. In total, 9 million shares were bought and sold for approximately $12.09 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.24 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 85.71% during the next 3 months and, with a 90% probability hold a price between $2.30 and $3.17 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

SLS Signals & Forecast

Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The SELLAS Life Sciences Group Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $1.41 and $1.29. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 23, 2024, and so far it has fallen -21.47%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for SELLAS Life Sciences Group Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.10 and $1.06. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, SELLAS Life Sciences Group Inc. finds support just below today's level at $1.10. If this is broken, then the next support from accumulated volume will be at $1.06 and $1.01.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.319 between high and low, or 28.51%. For the last week, the stock has had daily average volatility of 13.49%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SLS) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect SELLAS Life Sciences Group Inc. to open at $1.28, and during the day (based on 14 day Average True Range), to move between $1.12 and $1.44, which gives a possible trading interval of +/-$0.156 (+/-12.17%) up or down from last closing price. If SELLAS Life Sciences Group Inc. takes out the full calculated possible swing range there will be an estimated 24.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.31 (2.34%) than the support at $1.10 (14.06%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

SELLAS Life Sciences Group Inc. will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.210. We will update the financials statements for SELLAS Life Sciences Group Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.44% in the first trading day after earnings release.

Is SELLAS Life Sciences Group Inc. stock A Buy?

The SELLAS Life Sciences Group Inc. stock holds several negative signals and despite the positive trend, we believe SELLAS Life Sciences Group Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.326 Sell Candidate Unchanged

Predicted Opening Price for SELLAS Life Sciences Group Inc. of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$1.28 ( 0.0182%) $1.28

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for SLS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.60 24.93 %
R2 1.48 15.40 %
R1 1.40 9.51 %
Current price: 1.28
Support S1 1.16 -9.55 %
S2 1.08 -15.43 %
S3 0.96 -24.96 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.54 20.31 %
R2 1.40 9.37 %
R1 1.31 2.34 %
Current price 1.28
Support S1 1.10 -14.06%
S2 1.06 -17.19%
S3 1.01 -21.09%

SLS Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 09, 2010 Dec 09, 2010 Dec 20, 2010 $0.420 0.0005%
2 Sep 07, 2010 Sep 09, 2010 Sep 22, 2010 $0.150 0.0002%

FAQ

What is the symbol for SELLAS Life Sciences Group Inc. Stock and on which exchange is it traded?
The symbol for SELLAS Life Sciences Group Inc. is SLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell SELLAS Life Sciences Group Inc. Stock?
The SELLAS Life Sciences Group Inc. stock holds several negative signals and despite the positive trend, we believe SELLAS Life Sciences Group Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy SELLAS Life Sciences Group Inc. Stock?
SELLAS Life Sciences Group Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy SELLAS Life Sciences Group Inc. Stock.

What's the current price of SELLAS Life Sciences Group Inc. Stock?
As of the end of day on the May 01, 2024, the price of an SELLAS Life Sciences Group Inc. (SLS) share was $1.28.

What is the 52-week high and low for SELLAS Life Sciences Group Inc. Stock?
The 52-week high for SELLAS Life Sciences Group Inc. Stock is $1.91 and the 52-week low is $0.499.

What is the market capitalization of SELLAS Life Sciences Group Inc. Stock?
As of the May 01, 2024, the market capitalization of SELLAS Life Sciences Group Inc. is 72.023M.

When is the next earnings date for SELLAS Life Sciences Group Inc.?
The upcoming earnings date for SELLAS Life Sciences Group Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group. SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance... SLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT